SGLT2 Drugs That Extend Mouse Lifespan Carry a Real Ketoacidosis Risk, Concentrated in Predictable Patients

Coverage, in order

1. 11d ago
   
   Rapamycin News obscure n=282,282

   SGLT2 Drugs That Extend Mouse Lifespan Carry a Real Ketoacidosis Risk, Concentrated in Predictable Patients

   Researchers at Karolinska Institutet, Statens Serum Institut and Scandinavian partners used nationwide registers from Sweden, Denmark and Norway to study ketoacidosis in 282,282 adults with type 2 diabetes on SGLT2 inhibitors (mainly empagliflozin and dapagliflozin), covering 322,597 treatment…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.